The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2
Open accessAbstract
OBJECTIVE: To estimate the fraction of cervical intraepithelial neoplasia 2 (CIN 2) that might regress if untreated using data from the Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS). METHODS: We compared the cumulative occurrence of CIN 2 (n=397) and CIN 3 or more severe (n=542) diagnosed by the Pathology Quality Control Group in three trial arms-immediate colposcopy, human papillomavirus (HPV) triage, and conservative management-over the 2-year duration of the ALTS trial. A nonparametric test of trend was used to test for differences in the number of CIN 2 cases relative to number of CIN 3 or more severe cases across study arms with an increasing percentage of women referred to colposcopy at baseline. RESULTS: There were no significant differences in the cumulative 2-year cumulative CIN 3 or more severe diagnoses by study arm (10.9%, conservative management; 10.3%, HPV; 10.9%, immediate colposcopy) (Ptrend=.8), but there was a significant increase in CIN 2 diagnoses (5.8%, conservative management; 7.8%, HPV triage; 9.9%, immediate colposcopy) (Ptrend<.001) in the study arms, with increasing number of women referred to colposcopy at baseline. The relative differences in cumulative CIN 2 by study arm among women who tested HPV-16 positive at baseline were less pronounced (Ptrend=.1) than women who tested positive for other high-risk-HPV genotypes (Ptrend=.01). CONCLUSION: There was evidence that approximately 40% of undiagnosed CIN 2 will regress over 2 years, but CIN 2 caused by HPV-16 may be less likely to regress than CIN 2 caused by other high-risk-HPV genotypes. LEVEL OF EVIDENCE: II.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A wilcoxon‐type test for trend
Cuzick, J. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040112 · Cited by 1,900
The Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.03.003 · Cited by 1,144
Improved Amplification of Genital Human Papillomaviruses
Gravitt, P. E., Peyton, C. L., Alessi, T. Q., Wheeler, C. M., Coutlée, F., Hildesheim, A., Schiffman, M. H., Scott, D. R., & Apple, R. J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.1.357-361.2000 · Cited by 1,137
Self-citationStoler, M. H. (2001) · JAMA · doi:10.1001/jama.285.11.1500 · Cited by 1,087
Klaes, R., Friedrich, T., Spitkovsky, D., Ridder, R., Rudy, W., Petry, U., Dallenbach-Hellweg, G., Schmidt, D., & von Knebel Doeberitz, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1174 · Cited by 1,035
Solomon, D., Schiffman, M., & Tarone, R. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.293 · Cited by 975
Self-citation2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.047 · Cited by 841
Self-citationCarcinogenicity of human papillomaviruses
Cogliano, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., & Ghissassi, F. E. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70086-3 · Cited by 688
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00418-6 · Cited by 562
Klaes, R., Benner, A., Friedrich, T., Ridder, R., Herrington, S., Jenkins, D., Kurman, R. J., Schmidt, D., Stoler, M., & von Knebel Doeberitz, M. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200211000-00001 · Cited by 461
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.050 · Cited by 461
Self-citationThe carcinogenicity of human papillomavirus types reflects viral evolution
Schiffman, M., Herrero, R., DeSalle, R., Hildesheim, A., Wacholder, S., Cecilia Rodriguez, A., Bratti, M. C., Sherman, M. E., Morales, J., Guillen, D., et al. (2005) · Virology · doi:10.1016/j.virol.2005.04.002 · Cited by 441
Self-citation(ALTS) Group, T. A. S. C. O. U. S. /.-G. S. I. L. T. S. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.5.397 · Cited by 438
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.462 · Cited by 321
Kinney, W. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00080-5 · Cited by 274
(2003) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(03)00413-7 · Cited by 267
Meyskens, F. L., Surwit, E., Moon, T. E., Childers, J. M., Davis, J. R., Dorr, R. T., Johnson, C. S., & Alberts, D. S. (1994) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/86.7.539 · Cited by 263
Schiffman, M., & Adrianza, E. (2000) · Acta Cytologica · doi:10.1159/000328554 · Cited by 252
Self-citationDeterminants of Genital Human Papillomavirus Detection in a US Population
Peyton, C. L., Gravitt, P. E., Hunt, W. C., Hundley, R. S., Zhao, M., Apple, R. J., & Wheeler, C. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/320696 · Cited by 252
Self-citationTrimble, C. L., Piantadosi, S., Gravitt, P., Ronnett, B., Pizer, E., Elko, A., Wilgus, B., Yutzy, W., Daniel, R., Shah, K., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2599 · Cited by 234
Carreon, J. D., Sherman, M. E., Guillén, D., Solomon, D., Herrero, R., Jerónimo, J., Wacholder, S., Rodríguez, A. C., Morales, J., Hutchinson, M., et al. (2007) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31805152ab · Cited by 232
Self-citationCastle, P. E., Stoler, M. H., Solomon, D., Schiffmanx, M., & for the ALTS Group (2007) · American Journal of Clinical Pathology · doi:10.1309/pt3pnc1ql2f4d2vl · Cited by 202
Self-citationRestricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
Castle, P. E., SCHIFFMAN, M. H., Burk, R. D., Wacholder, S., Hildesheim, A., Herrero, R., Bratti, M. C., Sherman, M. E., & Lorincz, A. T. (2002) · PubMed · Cited by 197
Self-citationRisk assessment to guide the prevention of cervical cancer
Castle, P. E., Sideri, M., Jeronimo, J., Solomon, D., & Schiffman, M. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.049 · Cited by 179
Self-citationHuman Papillomavirus Genotype Specificity of Hybrid Capture 2
Castle, P. E., Solomon, D., Wheeler, C. M., Gravitt, P. E., Wacholder, S., & Schiffman, M. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00824-08 · Cited by 174
Self-citationMcIntyre‐Seltman, K., Castle, P. E., Guido, R. S., SCHIFFMAN, M. H., Wheeler, C. M., & for The ALTS Group (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0918 · Cited by 149
Self-citationKhan, M. J., Partridge, E. E., Wang, S., SCHIFFMAN, M. H., & Atypical Squamous Cells of Undetermined Significance/Low‐Grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group (2005) · Cancer · doi:10.1002/cncr.21129 · Cited by 95
Self-citationHeterogeneity in CIN3 diagnosis
Schiffman, M., & Rodríguez, A. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70110-4 · Cited by 88
Self-citationKeefe, K. A., Schell, M. J., Brewer, C., McHale, M., Brewster, W. B., Chapman, J. A., Rose, G. S., McMeeken, D. S., Lagerberg, W., Peng, Y. M., et al. (2001) · PubMed · Cited by 63
Zhang, Q., Kuhn, L., Denny, L., Souza, M. D., Taylor, S., & Wright, T. C. (2006) · International Journal of Cancer · doi:10.1002/ijc.22172 · Cited by 53
Cited by
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21139 · Cited by 1,390
Self-citationCarcinogenic human papillomavirus infection
Schiffman, M., Doorbar, J., Wentzensen, N., de Sanjosé, S., Fakhry, C., Monk, B. J., Stanley, M. A., & Franceschi, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.86 · Cited by 999
Self-citationRonco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Ghiringhello, B., Girlando, S., Gillio-Tos, A., De Marco, L., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 936
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J. M., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · Journal of Lower Genital Tract Disease · doi:10.1097/lgt.0b013e31824ca9d5 · Cited by 915
Self-citationSaslow, D., Solomon, D., Lawson, H. W., Killackey, M., Kulasingam, S. L., Cain, J., Garcia, F. A. R., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 791
Self-citation
Metadata
- Authors
- Castle, P. E., Schiffman, M., Wheeler, C. M., & Solomon, D.
- Venue
- Obstetrics & Gynecology
- Published
- 2009-01
- Volume
- 113
- Issue
- 1
- Pages
- 18-25
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W2041694981
- Cited by
- 384
- References
- 30
- FWCI
- 19.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.